The clock keeps ticking for intravenous methylprednisolone

J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):788. doi: 10.1136/jnnp.2006.109272.

Abstract

Patients with multiple sclerosis may benefit more from night‐time rather than daytime infusion

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Circadian Rhythm
  • Humans
  • Methylprednisolone / administration & dosage*
  • Multiple Sclerosis / drug therapy*
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Methylprednisolone